Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
35 hedge funds and large institutions have $212M invested in Alimera Sciences in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
45% more capital invested
Capital invested by funds: $146M → $212M (+$65.8M)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
17% more funds holding
Funds holding: 30 → 35 (+5)
0% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$3.94M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.7M |
| 3 |
BlackRock
New York
|
+$1.5M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$943K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$420K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$926K |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$775K |
| 3 |
CC
Clearline Capital
New York
|
-$561K |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$495K |
| 5 |
Millennium Management
New York
|
-$194K |
ALIM Hedge Fund Activity: Q4 2023 in Review
35 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q4 2023, worth a combined $212M — up 45% from $146M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ALIM positions and 3 closed out — a net gain of 5 holders — while 9 added to existing stakes and 9 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $3.94M. The largest seller was Altium Capital Management, cutting an estimated $926K.
- 35 institutional investors held Alimera Sciences (ALIM) as of Q4 2023, up from 30 in Q3 2023.
- Funds reported $212M of Alimera Sciences stock for Q4 2023, up 45% quarter-over-quarter.
- 8 funds opened new Alimera Sciences positions in Q4 2023 and 3 closed out, a net change of +5 holders.
- The largest Alimera Sciences buyer in Q4 2023 was Morgan Stanley, an estimated $3.94M added.
- The largest Alimera Sciences seller in Q4 2023 was Altium Capital Management, an estimated $926K sold.
Based on aggregated 13F filings for Q4 2023.